UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058076
Receipt number R000066374
Scientific Title Examination of the relationship between blood concentrations of remimazolam and BIS and PSI values
Date of disclosure of the study information 2025/06/04
Last modified on 2025/06/04 09:15:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the relationship between blood concentrations of remimazolam and BIS and PSI values

Acronym

Examination of the relationship between blood concentrations of remimazolam and BIS and PSI values

Scientific Title

Examination of the relationship between blood concentrations of remimazolam and BIS and PSI values

Scientific Title:Acronym

Examination of the relationship between blood concentrations of remimazolam and BIS and PSI values

Region

Japan


Condition

Condition

Patients who underwent surgery under remimazolam anesthesia at Kyushu University Hospital

Classification by specialty

Surgery in general Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Remimazolam has been reported to have higher BIS and PSI values than propofol during optimal sedation. However, these reports define optimal sedation based on hemodynamic parameters such as blood pressure, without considering plasma concentrations. Using a plasma concentration simulator tailored to the characteristics of remimazolam, we will compare plasma concentrations with BIS and PSI values.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between blood concentration at bedtime and time until awakening

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients who underwent surgery at Kyushu University Hospital under remimazolam anesthesia
(2) Patients aged 18 years or older at the time of surgery
(3) Patients who had a BIS monitor and SedLine monitor attached at the time of surgery
(4) ASA status 3 or lower.

Key exclusion criteria

(1) Individuals who underwent surgery using methods other than general anesthesia (local anesthesia).
(2) Surgery performed in the prone position.
(3) Surgery using artificial heart-lung support.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name kazuhiro
Middle name
Last name shirozu

Organization

kyushu university hospital

Division name

operating rooms

Zip code

812-8582

Address

3-1-1 Maidashi Higashi-ku fukuoka

TEL

092-642-5714

Email

shirozu.kazuhiro.334@m.kyushu-u.ac.jp


Public contact

Name of contact person

1st name kazuhiro
Middle name
Last name shirozu

Organization

kyushu university hospital

Division name

operating rooms

Zip code

812-8582

Address

3-1-1 Maidashi Higashi-ku fukuoka

TEL

092-642-5714

Homepage URL


Email

shirozu.kazuhiro.334@m.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center for Clinical and Translational Research.

Address

3-1-1 Maidashi Higashi-ku fukuoka

Tel

092-642-5858

Email

tr-info@med.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

23260-01

Org. issuing International ID_1

23260-01

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

100

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 02 Month 28 Day

Date of IRB

2024 Year 02 Month 28 Day

Anticipated trial start date

2024 Year 02 Month 28 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2025 Year 06 Month 04 Day

Last modified on

2025 Year 06 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066374